Effective August 2, 2022, mdxhealth has acquired the Oncotype DX GPS (Genomic Prostate Score) test from Exact Sciences. To help ensure a smooth transition for patients, continue to place orders for this test through the existing Exact Sciences portal until further notice. Additionally, Genomic Health Inc, part of Exact Sciences, will continue to perform the Oncotype DX GPS test during the transition. Further communications explaining transition plans will be provided in the coming months. For more details, please review the following press release. Questions? Email: gps@mdxhealth.com

Sri Kalluri

Chief Information Officer

Joined Exact Sciences: 2022

Sri Kalluri joined as the Chief Information Officer in May 2022. Mr. Kalluri brings over 20 years of experience and is responsible for IT operations, leveraging cutting-edge technology to unlock breakthrough levels of corporate revenue growth, productivity, and market expansion, and defining, executing and managing a successful customer experience. Prior to joining Exact Sciences, Mr. Kalluri served as Vice President & Chief Information Officer at Cepheid, where he was responsible for scaling IT capabilities, infrastructure, and strategy to support the growth of the company’s workforce. Mr. Kalluri also held leadership roles at Beckman Coulter.

Mr. Kalluri earned his MBA at University of Southern California, Marshall School of Business and his bachelor’s degree in Engineering from Osmania University, India.